M&ABioNTech bags Instadeep for £562mBioNTech SE will pay £562m in cash to acquire its former partner InstaDeep Ltd. to expand its capabilities in AI-based drug discovery. more ➔
ApprovalRoche withdraws checkpoint blocker from th...Roche AGs US subsidiary Genentech Inc has withdrawn its checkpoint inhibitor atezolizumab from the market after disappointing results in bladder cancer. more ➔
Novo Holdings invests into standardisation...Evosep APS has inked a $40m funding deal with Novo Holdings A/S that is aimed to advance standardised clinical LC-MS-based drug discovery and diagnostic multi-marker tests. more ➔
financingExeVir receives EIB risk finance for multi...With the help of a €25m loan from the European Investment Bank, ExeVir BIO BV will advance clinical trials with its COVID-19 nanobody XVR012. more ➔
partnershipHummingbird and Synaffix in $150m ADC dealRational antibody design specialist Hummingbird Bioscience has licenced a cancer target and the modular ADC technology of Dutch Synaffix BV. more ➔
partnershipEthris inks €15m deal with Indian CiplasCipla EU Ltd is going to make an equity investment of €15m in Ethris GmbH, a specialist for respiratory delivery of therapeutic mRNAs. more ➔
MSFirst hints for leukopenia diagnostic in M...Scientists from the University of Basel and the University Hospital Basel have found that two bacterial species may indicate multiple sclerosis-associated lymphopenia. more ➔
PartnershipCollaboration to develop mRNA vaccine agai...CEPI fights the betacoronaviruses by funding Ethris GmbH and DIOSynVax Ltd and their joint effort to advance their work on an mRNA vaccine. more ➔
immunoncologyFirst allogeneic cancer immunotherapy hits...Atara Biotherapeutics Inc. and Pierre Fabre SA announced the approval of Tabelecleucel, a therapy for a rare and potentially fatal malignancy. more ➔
financingNumares AG cashes in €20m from EIBThe European Investment Bank (EIB) is going to support the AI-platform of NMR/metabolomics diagnostics company Numares AG to improve disease prediction. more ➔
